Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning.
作者信息
Nolan Erin E, Durose Willa, Taghizadeh Leyla A, King Carina J, Gupta Ashish O, Orchard Paul J, Lorentson Maggie, Braaten Kai, Furcich Justin W, Lund Troy C
机构信息
Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, MN.
出版信息
Blood Adv. 2023 Dec 12;7(23):7290-7294. doi: 10.1182/bloodadvances.2023010923.
Abstract
摘要
相似文献
1
Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning.
Blood Adv. 2023 Dec 12;7(23):7290-7294. doi: 10.1182/bloodadvances.2023010923.
2
An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning.
Transplantation. 2005 Nov 15;80(9):1145-52. doi: 10.1097/01.tp.0000183289.79693.3d.
3
Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation.
J Immunol. 2012 Aug 15;189(4):1661-70. doi: 10.4049/jimmunol.1103199. Epub 2012 Jul 13.
4
Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Transplantation. 2003 Jul 15;76(1):216-24. doi: 10.1097/01.TP.0000069602.30162.A1.
5
Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Biol Blood Marrow Transplant. 2003 Jul;9(7):453-9. doi: 10.1016/s1083-8791(03)00139-3.
6
Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Biol Blood Marrow Transplant. 2001;7(12):646-55. doi: 10.1053/bbmt.2001.v7.pm11787527.
7
Strategic nonmyeloablative conditioning: CD154:CD40 costimulatory blockade at primary bone marrow transplantation promotes engraftment for secondary bone marrow transplantation after engraftment failure.
J Immunol. 2008 Nov 1;181(9):6616-24. doi: 10.4049/jimmunol.181.9.6616.
8
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
Biol Blood Marrow Transplant. 2003 Aug;9(8):519-28. doi: 10.1016/s1083-8791(03)00192-7.
9
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant. 2001;7(9):473-85. doi: 10.1053/bbmt.2001.v7.pm11669214.
本文引用的文献
1
Donor bone marrow-derived macrophage engraftment into the central nervous system of patients following allogeneic transplantation.
Blood Adv. 2023 Oct 10;7(19):5851-5859. doi: 10.1182/bloodadvances.2023010409.
2
Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
Int J Mol Sci. 2022 Apr 27;23(9):4854. doi: 10.3390/ijms23094854.
3
Treatment of a genetic brain disease by CNS-wide microglia replacement.
Sci Transl Med. 2022 Mar 16;14(636):eabl9945. doi: 10.1126/scitranslmed.abl9945.
4
Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain.
Nat Med. 2022 Mar;28(3):517-527. doi: 10.1038/s41591-022-01691-9. Epub 2022 Feb 21.
5
Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
Blood. 2022 Mar 3;139(9):1389-1408. doi: 10.1182/blood.2021011671.
6
Efficient Strategies for Microglia Replacement in the Central Nervous System.
Cell Rep. 2020 Nov 24;33(8):108443. doi: 10.1016/j.celrep.2020.108443.
7
Neuroprotective Properties and Therapeutic Potential of Bone Marrow-Derived Microglia in Alzheimer's Disease.
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520927169. doi: 10.1177/1533317520927169.
8
Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer's disease.
Commun Biol. 2020 Feb 13;3(1):69. doi: 10.1038/s42003-020-0797-4.
9
Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
J Alzheimers Dis. 2018;64(2):563-585. doi: 10.3233/JAD-170994.
10
Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
Behav Brain Res. 2017 May 1;324:30-40. doi: 10.1016/j.bbr.2017.02.005. Epub 2017 Feb 3.
Zotero 插件